Home LiteratureArticle Details
PMID: 15602020 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Inflammatory markers and the risk of coronary heart disease in men and women.

The New England journal of medicine ·Vol. 351 ·No. 25 ·2004-12-16 ·Pages 2599-610

Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB

Abstract

Few studies have simultaneously investigated the role of soluble tumor necrosis factor alpha (TNF-alpha) receptors types 1 and 2 (sTNF-R1 and sTNF-R2), C-reactive protein, and interleukin-6 as predictors of cardiovascular events. The value of these inflammatory markers as independent predictors remains controversial. We examined plasma levels of sTNF-R1, sTNF-R2, interleukin-6, and C-reactive protein as markers of risk for coronary heart disease among women participating in the Nurses' Health Study and men participating in the Health Professionals Follow-up Study in nested case-control analyses. Among participants who provided a blood sample and who were free of cardiovascular disease at baseline, 239 women and 265 men had a nonfatal myocardial infarction or fatal coronary heart disease during eight years and six years of follow-up, respectively. Using risk-set sampling, we selected controls in a 2:1 ratio with matching for age, smoking status, and date of blood sampling. After adjustment for matching factors, high levels of interleukin-6 and C-reactive protein were significantly related to an increased risk of coronary heart disease in both sexes, whereas high levels of soluble TNF-alpha receptors were significant only among women. Further adjustment for lipid and nonlipid factors attenuated all associations; only C-reactive protein levels remained significant. The relative risk among all participants was 1.79 for those with C-reactive protein levels of at least 3.0 mg per liter, as compared with those with levels of less than 1.0 mg per liter (95 percent confidence interval, 1.27 to 2.51; P for trend <0.001). Additional adjustment for the presence or absence of diabetes and hypertension moderately attenuated the relative risk to 1.68 (95 percent confidence interval, 1.18 to 2.38; P for trend = 0.008). Elevated levels of inflammatory markers, particularly C-reactive protein, indicate an increased risk of coronary heart disease. Although plasma lipid levels were more strongly associated with an increased risk than were inflammatory markers, the level of C-reactive protein remained a significant contributor to the prediction of coronary heart disease.

MeSH Terms
Adult Aged C-Reactive Protein/analysis Cardiovascular Diseases/blood,epidemiology,immunology Case-Control Studies Female Follow-Up Studies Humans Interleukin-6/blood Logistic Models Male Middle Aged Multivariate Analysis Receptors, Tumor Necrosis Factor, Type I/blood Receptors, Tumor Necrosis Factor, Type II/blood Risk Sex Factors
Chemicals
Interleukin-6 Receptors, Tumor Necrosis Factor, Type I Receptors, Tumor Necrosis Factor, Type II C-Reactive Protein
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Pai Jennifer K
Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA.
Pischon Tobias
Ma Jing
Manson JoAnn E
Hankinson Susan E
Joshipura Kaumudi
Curhan Gary C
Rifai Nader
Cannuscio Carolyn C
Stampfer Meir J
Rimm Eric B
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
Published
2004-12-16
Pages
2599-610
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Grants
NIAAA NIH HHS · AA11181 · United States
NCI NIH HHS · CA55075 · United States
NHLBI NIH HHS · HL07575 · United States
NHLBI NIH HHS · HL34594 · United States
NHLBI NIH HHS · HL35464 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]